Thrombospondin 1 synthesis and function in wound repair.
PDF (2.9M)
Journal: 1996/August - American Journal of Pathology
ISSN: 0002-9440
PUBMED: 8669471
Abstract:
Thrombospondin 1 (TSP1) is a multifunctional extracellular matrix molecule that belongs to a family of homologous glycoproteins. TSP1 can be produced by many cell types that are involved in wound repair, including keratinocytes, fibroblasts, endothelial cells, and macrophages. To investigate the kinetics of TSP1 synthesis in wounds, mRNA from murine full thickness excisional dermal wounds was analyzed. TSP1 mRNA was undetectable in normal skin but was present in early wounds. After day 1, TSP1 mRNA levels within wounds slowly decreased, returning to undectable day 10. In situ hybridization revealed that the primary source of the TSP1 mRNA within wounds was macrophage-like cells in the inflammatory infiltrate. To explore the function of TSP1 production in sites of injury, wounds were treated with antisense TSP1 oligomers. Antisense-treated wounds contained 55 to 66% less TSP1-positive macrophages than control and exhibited a marked delay in repair. This delay included a decreased rate of re-epithelialization as well as a delay in dermal reorganization. The results suggest that TSP1 production by macrophages facilitates the repair process and provide evidence that TSP1 production is an important component of optimal wound healing.
Open in
PUBMED | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(46)
References
(45)
Diseases
(1)
Chemicals
(3)
Organisms
(3)
Processes
(3)
Anatomy
(2)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Am J Pathol 148(6): 1851-1860
PMID: 8669471

Thrombospondin 1 synthesis and function in wound repair.

Abstract

Thrombospondin 1 (TSP1) is a multifunctional extracellular matrix molecule that belongs to a family of homologous glycoproteins. TSP1 can be produced by many cell types that are involved in wound repair, including keratinocytes, fibroblasts, endothelial cells, and macrophages. To investigate the kinetics of TSP1 synthesis in wounds, mRNA from murine full thickness excisional dermal wounds was analyzed. TSP1 mRNA was undetectable in normal skin but was present in early wounds. After day 1, TSP1 mRNA levels within wounds slowly decreased, returning to undectable day 10. In situ hybridization revealed that the primary source of the TSP1 mRNA within wounds was macrophage-like cells in the inflammatory infiltrate. To explore the function of TSP1 production in sites of injury, wounds were treated with antisense TSP1 oligomers. Antisense-treated wounds contained 55 to 66% less TSP1-positive macrophages than control and exhibited a marked delay in repair. This delay included a decreased rate of re-epithelialization as well as a delay in dermal reorganization. The results suggest that TSP1 production by macrophages facilitates the repair process and provide evidence that TSP1 production is an important component of optimal wound healing.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.9M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 1851
1851
icon of scanned page 1852
1852
icon of scanned page 1853
1853
icon of scanned page 1854
1854
icon of scanned page 1855
1855
icon of scanned page 1856
1856
icon of scanned page 1857
1857
icon of scanned page 1858
1858
icon of scanned page 1859
1859
icon of scanned page 1860
1860

Images in this article

Figure 1
Figure 1
on p.1854
Figure 2
Figure 2
on p.1855
Figure 3
Figure 3
on p.1856
Figure 5
Figure 5
on p.1857
Figure 6
Figure 6
on p.1858
Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Lawler J. The structural and functional properties of thrombospondin. Blood. 1986 May;67(5):1197–1209. [PubMed] [Google Scholar]
  • Frazier WA. Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells. J Cell Biol. 1987 Aug;105(2):625–632.[PMC free article] [PubMed] [Google Scholar]
  • Wikner NE, Dixit VM, Frazier WA, Clark RA. Human keratinocytes synthesize and secrete the extracellular matrix protein, thrombospondin. J Invest Dermatol. 1987 Feb;88(2):207–211. [PubMed] [Google Scholar]
  • Varani J, Nickoloff BJ, Riser BL, Mitra RS, O'Rourke K, Dixit VM. Thrombospondin-induced adhesion of human keratinocytes. J Clin Invest. 1988 May;81(5):1537–1544.[PMC free article] [PubMed] [Google Scholar]
  • Mumby SM, Abbott-Brown D, Raugi GJ, Bornstein P. Regulation of thrombospondin secretion by cells in culture. J Cell Physiol. 1984 Sep;120(3):280–288. [PubMed] [Google Scholar]
  • Tuszynski GP, Rothman V, Murphy A, Siegler K, Smith L, Smith S, Karczewski J, Knudsen KA. Thrombospondin promotes cell-substratum adhesion. Science. 1987 Jun 19;236(4808):1570–1573. [PubMed] [Google Scholar]
  • Lahav J. Thrombospondin inhibits adhesion of endothelial cells. Exp Cell Res. 1988 Jul;177(1):199–204. [PubMed] [Google Scholar]
  • Murphy-Ullrich JE, Hök M. Thrombospondin modulates focal adhesions in endothelial cells. J Cell Biol. 1989 Sep;109(3):1309–1319.[PMC free article] [PubMed] [Google Scholar]
  • Taraboletti G, Roberts D, Liotta LA, Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol. 1990 Aug;111(2):765–772.[PMC free article] [PubMed] [Google Scholar]
  • DiPietro LA, Nebgen DR, Polverini PJ. Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J Vasc Res. 1994 May-Jun;31(3):178–185. [PubMed] [Google Scholar]
  • Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6624–6628.[PMC free article] [PubMed] [Google Scholar]
  • Iruela-Arispe ML, Bornstein P, Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):5026–5030.[PMC free article] [PubMed] [Google Scholar]
  • Rastinejad F, Polverini PJ, Bouck NP. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell. 1989 Feb 10;56(3):345–355. [PubMed] [Google Scholar]
  • Varani J, Carey TE, Fligiel SE, McKeever PE, Dixit V. Tumor type-specific differences in cell-substrate adhesion among human tumor cell lines. Int J Cancer. 1987 Mar 15;39(3):397–403. [PubMed] [Google Scholar]
  • Pratt DA, Miller WR, Dawes J. Thrombospondin in malignant and non-malignant breast tissue. Eur J Cancer Clin Oncol. 1989 Feb;25(2):343–350. [PubMed] [Google Scholar]
  • Koch AE, Friedman J, Burrows JC, Haines GK, Bouck NP. Localization of the angiogenesis inhibitor thrombospondin in human synovial tissues. Pathobiology. 1993;61(1):1–6. [PubMed] [Google Scholar]
  • Botney MD, Kaiser LR, Cooper JD, Mecham RP, Parghi D, Roby J, Parks WC. Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries. Am J Pathol. 1992 Feb;140(2):357–364.[PMC free article] [PubMed] [Google Scholar]
  • DiPietro LA, Polverini PJ. Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1. Am J Pathol. 1993 Sep;143(3):678–684.[PMC free article] [PubMed] [Google Scholar]
  • Varani J, Stoolman L, Wang T, Schuger L, Flippen C, Dame M, Johnson KJ, Todd RF, 3rd, Ryan US, Ward PA. Thrombospondin production and thrombospondin-mediated adhesion in U937 cells. Exp Cell Res. 1991 Jul;195(1):177–182. [PubMed] [Google Scholar]
  • Ostergaard E, Flodgaard H. A neutrophil-derived proteolytic inactive elastase homologue (hHBP) mediates reversible contraction of fibroblasts and endothelial cell monolayers and stimulates monocyte survival and thrombospondin secretion. J Leukoc Biol. 1992 Apr;51(4):316–323. [PubMed] [Google Scholar]
  • Jaffe EA, Ruggiero JT, Falcone DJ. Monocytes and macrophages synthesize and secrete thrombospondin. Blood. 1985 Jan;65(1):79–84. [PubMed] [Google Scholar]
  • Ross R, Odland G. Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations, and fibrogenesis. J Cell Biol. 1968 Oct;39(1):152–168.[PMC free article] [PubMed] [Google Scholar]
  • Bonini JA, Hofmann C. A rapid, accurate, nonradioactive method for quantitating RNA on agarose gels. Biotechniques. 1991 Dec;11(6):708–710. [PubMed] [Google Scholar]
  • Lawler J, Duquette M, Ferro P, Copeland NG, Gilbert DJ, Jenkins NA. Characterization of the murine thrombospondin gene. Genomics. 1991 Nov;11(3):587–600. [PubMed] [Google Scholar]
  • Simons M, Edelman ER, DeKeyser JL, Langer R, Rosenberg RD. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature. 1992 Sep 3;359(6390):67–70. [PubMed] [Google Scholar]
  • Hume DA, Perry VH, Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localisation of antigen F4/80: macrophages associated with epithelia. Anat Rec. 1984 Nov;210(3):503–512. [PubMed] [Google Scholar]
  • Wight TN, Raugi GJ, Mumby SM, Bornstein P. Light microscopic immunolocation of thrombospondin in human tissues. J Histochem Cytochem. 1985 Apr;33(4):295–302. [PubMed] [Google Scholar]
  • Reed MJ, Puolakkainen P, Lane TF, Dickerson D, Bornstein P, Sage EH. Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem. 1993 Oct;41(10):1467–1477. [PubMed] [Google Scholar]
  • Raugi GJ, Olerud JE, Gown AM. Thrombospondin in early human wound tissue. J Invest Dermatol. 1987 Dec;89(6):551–554. [PubMed] [Google Scholar]
  • DiPietro LA, Polverini PJ, Rahbe SM, Kovacs EJ. Modulation of JE/MCP-1 expression in dermal wound repair. Am J Pathol. 1995 Apr;146(4):868–875.[PMC free article] [PubMed] [Google Scholar]
  • Huber AR, Ellis S, Johnson KJ, Dixit VM, Varani J. Monocyte diapedesis through an in vitro vessel wall construct: inhibition with monoclonal antibodies to thrombospondin. J Leukoc Biol. 1992 Nov;52(5):524–528. [PubMed] [Google Scholar]
  • Mansfield PJ, Suchard SJ. Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol. 1994 Nov 1;153(9):4219–4229. [PubMed] [Google Scholar]
  • Silverstein RL, Asch AS, Nachman RL. Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest. 1989 Aug;84(2):546–552.[PMC free article] [PubMed] [Google Scholar]
  • Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol. 1975 Jan;78(1):71–100.[PMC free article] [PubMed] [Google Scholar]
  • Hunt TK. The physiology of wound healing. Ann Emerg Med. 1988 Dec;17(12):1265–1273. [PubMed] [Google Scholar]
  • Kovacs EJ, DiPietro LA. Fibrogenic cytokines and connective tissue production. FASEB J. 1994 Aug;8(11):854–861. [PubMed] [Google Scholar]
  • Schultz-Cherry S, Murphy-Ullrich JE. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol. 1993 Aug;122(4):923–932.[PMC free article] [PubMed] [Google Scholar]
  • Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J Biol Chem. 1994 Oct 28;269(43):26775–26782. [PubMed] [Google Scholar]
  • Whitby DJ, Ferguson MW. Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol. 1991 Sep;147(1):207–215. [PubMed] [Google Scholar]
  • Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science. 1987 Sep 11;237(4820):1333–1336. [PubMed] [Google Scholar]
  • Hogg PJ, Owensby DA, Mosher DF, Misenheimer TM, Chesterman CN. Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase. J Biol Chem. 1993 Apr 5;268(10):7139–7146. [PubMed] [Google Scholar]
  • Hogg PJ, Owensby DA, Chesterman CN. Thrombospondin 1 is a tight-binding competitive inhibitor of neutrophil cathepsin G. Determination of the kinetic mechanism of inhibition and localization of cathepsin G binding to the thrombospondin 1 type 3 repeats. J Biol Chem. 1993 Oct 15;268(29):21811–21818. [PubMed] [Google Scholar]
  • Hogg PJ, Stenflo J, Mosher DF. Thrombospondin is a slow tight-binding inhibitor of plasmin. Biochemistry. 1992 Jan 14;31(1):265–269. [PubMed] [Google Scholar]
  • Mosher DF, Misenheimer TM, Stenflo J, Hogg PJ. Modulation of fibrinolysis by thrombospondin. Ann N Y Acad Sci. 1992 Dec 4;667:64–69. [PubMed] [Google Scholar]
  • Savill J, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest. 1992 Oct;90(4):1513–1522.[PMC free article] [PubMed] [Google Scholar]
Burn and Shock Trauma Institute, Loyola University Medical Center, IL 60153, USA.
Burn and Shock Trauma Institute, Loyola University Medical Center, IL 60153, USA.
Copyright notice
Abstract
Thrombospondin 1 (TSP1) is a multifunctional extracellular matrix molecule that belongs to a family of homologous glycoproteins. TSP1 can be produced by many cell types that are involved in wound repair, including keratinocytes, fibroblasts, endothelial cells, and macrophages. To investigate the kinetics of TSP1 synthesis in wounds, mRNA from murine full thickness excisional dermal wounds was analyzed. TSP1 mRNA was undetectable in normal skin but was present in early wounds. After day 1, TSP1 mRNA levels within wounds slowly decreased, returning to undectable day 10. In situ hybridization revealed that the primary source of the TSP1 mRNA within wounds was macrophage-like cells in the inflammatory infiltrate. To explore the function of TSP1 production in sites of injury, wounds were treated with antisense TSP1 oligomers. Antisense-treated wounds contained 55 to 66% less TSP1-positive macrophages than control and exhibited a marked delay in repair. This delay included a decreased rate of re-epithelialization as well as a delay in dermal reorganization. The results suggest that TSP1 production by macrophages facilitates the repair process and provide evidence that TSP1 production is an important component of optimal wound healing.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.